Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
Background: Ketamine is an effective antidepressant with a 65–70% response rate and a fast onset of action. Esketamine (S-ketamine) has been found to be twice as potent as R-ketamine, while inducing fewer adverse effects, such as sedation and cognitive impairment, than racemic ketamine. However, lit...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Journal of Affective Disorders Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666915320300536 |